Dr. Mikael Dolsten Named to Agilent Board of Directors
Pfizer executive brings strong scientific and medical expertise to Agilent board SANTA CLARA, Calif., September 23, 2021 Agilent Technologies, Inc. (NYSE: A) today announced that Dr. Mikael Dolsten, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer Inc. has been elected to Agilent’s board of directors, effective Sept. 21, 2021. Dr. Dolsten brings... Read more